Platform Technology Partners Has $1.21 Million Position in The Clorox Company (NYSE:CLX)

Platform Technology Partners grew its position in The Clorox Company (NYSE:CLXFree Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The firm owned 7,438 shares of the company’s stock after buying an additional 208 shares during the quarter. Platform Technology Partners’ holdings in Clorox were worth $1,208,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of CLX. Brooklyn Investment Group boosted its stake in Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the 3rd quarter valued at about $27,000. Continuum Advisory LLC raised its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after buying an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC acquired a new position in Clorox during the third quarter worth $48,000. Finally, Friedenthal Financial bought a new position in Clorox during the 3rd quarter valued at about $49,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of CLX stock opened at $148.51 on Friday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company’s fifty day simple moving average is $161.44 and its 200-day simple moving average is $158.59. The firm has a market cap of $18.38 billion, a PE ratio of 51.75, a P/E/G ratio of 2.92 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 4.78% and a return on equity of 316.08%. During the same quarter in the prior year, the business posted $2.16 earnings per share. Equities research analysts expect that The Clorox Company will post 6.86 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is currently 170.04%.

Analyst Ratings Changes

CLX has been the subject of a number of recent analyst reports. Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Barclays boosted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday. Royal Bank of Canada reiterated a “sector perform” rating and set a $150.00 target price on shares of Clorox in a report on Thursday, January 30th. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday. Four investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $158.21.

Read Our Latest Stock Report on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.